Sandra Peterson

Sandra E.
Peterson currently works at Cynosure LLC, as Chairman from 2019, Aster Insights, as Chairman, Cynosure, Inc. (Massachusetts), as Chairman, Volastra Therapeutics, Inc., as Executive Chairman from 2019, Microsoft Corp., as Lead Independent Director from 2023, Institute for Advanced Study, as Director from 2015, Lotus Parent, Inc., as Director, M2gen Holdings LP, as Director, Seaport Therapeutics, Inc., as Independent Director from 2024, American Academy in Berlin GmbH, as Trustee from 2013, Women's Forum, Inc., as Member, C200 Foundation, as Member, and Clayton Dubilier & Rice LLC, as Operating Partner from 2019.
Ms. Peterson also formerly worked at Bayer Medical Care, Inc., as Chief Executive Officer, Bayer CropScience AG, as Chief Executive Officer in 2012, Johnson & Johnson, as Chairman-Worldwide Group from 2012 to 2018, EcoHealth Alliance, Inc., as Chairman, Handleman Co., as Director from 2001 to 2005, The Dun & Bradstreet Corp., as Independent Director from 2011 to 2015, Covetrus, Inc., as Independent Director from 2020 to 2022, Zymergen, Inc., as Independent Director from 2019 to 2021, Medco Health Solutions, Inc., as Group President-Government from 2003 to 2004, Bayer Healthcare LLC, as Executive VP & President-Medical Care from 2009 to 2010, Merck-Medco Managed Care LLC, as Senior Vice President-Marketing from 1999 to 2001, Bayer HealthCare AG, as Member-Management Board, Women Corporate Directors, as Member, and Bayer Diabetes Care, as President.
Ms. Peterson received her undergraduate degree from Cornell University and graduate degree from Princeton University.